New York Times: Results Are Promising in Clinical Trial of Dengue Fever Vaccine
“The French pharmaceutical company Sanofi said on Monday that its experimental vaccine for dengue fever had succeeded in its first late-stage clinical trial. The results could help pave the way for the introduction of the first vaccine to prevent a disease that afflicts an estimated 50 million to 100 million people a year…” (Pollack, 4/28).